 SOMERSET, N.J.--BUSINESS WIRE--- LEGN ASCO21--Legend Biotech Corporation NASDAQ: LEGN Legend Biotech, a global clinical-stage biopharmaceutical company engaged in the discovery and development of novel cell therapies for oncology and other indications, today announced that 15 abstracts have been accepted at the upcoming 2021 American Society of Clinical Oncology ASCO Annual Meeting and the European Hematology Associations EHA 2021 Virtual Congress, including new and updated data from the CARTITUDE 